[1]曾祥烨 王蔚宗 周桐羽 杜晓诗 孟庆欣 李丙松 高梅.冠状动脉扩张症：非冠状动脉粥样硬化性心脏病的特殊类型[J].心血管病学进展,2024,(10):902.[doi:10.16806/j.cnki.issn.1004-3934.2024.10.008]
　ZENG Xiangye,WANG Weizong,ZHOU Tongyu,et al.Coronary Artery Ectasia:A Specialized Type of Non-Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2024,(10):902.[doi:10.16806/j.cnki.issn.1004-3934.2024.10.008]
点击复制

冠状动脉扩张症：非冠状动脉粥样硬化性心脏病的特殊类型()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2024年10期
页码:
902
栏目:
综述
出版日期:
2024-10-25

文章信息/Info

Title:
Coronary Artery Ectasia:A Specialized Type of Non-Coronary Atherosclerotic Heart Disease
作者:
曾祥烨1 王蔚宗1 周桐羽1 杜晓诗2 孟庆欣1 李丙松3 高梅1; 2; 3
(1.山东第一医科大学第一附属医院 山东省千佛山医院心 血管病学科 山东省医药卫生心律失常重点实验室,山东 济南,2500 14; 2.山东中医药大学第二临床医学院,山东 济南,250014;3.山东第二医科大学临床医学院,山东 潍坊,261000)
Author(s):
ZENG Xiangye1; WANG Weizong1; ZHOU Tongyu1; DU Xiaoshi2; MENG Qingxin1; LI Bingsong3; GAO Mei1; 2; 3
(1.Department of Cardiology,The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital,Shandong Medicine and Health Key Laboratory of Cardiac Electrophysiology and Arrhythmia,Jinan 250014,Shandong,China;2.The Second Clinical College of Shandong University of Traditional Chinese Medicine,Jinan 250014,Shandong,China;3.School of Clinical Medicine,Shandong Second Medical University, Weifang 261000,Shandong,China)
关键词:
冠状动脉扩张症; 冠状动脉粥样硬化性心脏病; 炎症; 脂质代谢
Keywords:
Coronary artery ectasia; Coronary atherosclerotic heart disease; Inflammation; Lipid metabolism
DOI:
10.16806/j.cnki.issn.1004-3934.2024.10.008
摘要:
冠状动脉扩张症（CAE）是临床上少见的一类心血管疾病，定义为冠状动脉节段性或弥漫性扩张，扩张处直径≥1.5 倍相邻的正常血管直径。CAE发病率在0.3%～5%之间，临床表现主要包括典型心绞痛，非典型心绞痛或心肌梗死。该病病因尚未明确。因多数CAE患者合并冠状动脉粥样硬化性心脏病（CAD），早期研究认为CAE是CAD的一种特殊类型。然而此类观点一直存在争议，随着研究的深入，发现CAE患者有着独特的细胞因子环境及血脂谱，因此CAE可能是单独的一类临床疾病。现从动脉粥样硬化、炎症、脂质代谢等方面总结CAE和CAD的差异，并对CAE临床表现、预后、诊断和治疗方面作一综述。
Abstract:
Coronary artery ectasia (CAE) is a rare clinical cardiovascular disease defined as segmental or diffuse dilatation of coronary arteries ≥1.5 times the diameter of adjacent normal vessels. The prevalence of CAE is between 0.3% and 5%,and the clinical manifestations mainly include typical angina,atypical angina,or myocardial infarction. The etiology of CAE has not yet been clarified. Due to most patients with CAE combined with coronary atherosclerotic heart disease (CAD) ,early studies considered CAE as a specific type of CAD. However,such views have been controversial. Further research found that patients with CAE have a unique cytokine milieu and lipid profile. Therefore,CAE may be a separate category of clinical disease. This article summarizes the differences between CAE and CAD in terms of atherosclerosis,inflammation,and lipid metabolism,and provides an overview of the clinical manifestations,prognosis,diagnosis,and treatment of CAE

参考文献/References:

[1] Swaye PS,Fisher LD,Litwin P,et al. Aneurysmal coronary artery disease [J]. Circulation, 1983 ,67(1):134-138.

[2] 管浩,崔锦钢,胡奉环,等. 冠状动脉扩张症患者的临床特征及新分型指导介入治疗的效果观察[J]. 中国循环杂志,2021,36(2):131-136.

[3] Rashid S,Gul U,Ali M,et al. Coronary artery ectasia:clinical and angiographic features[J]. J Coll Physicians Surg Pak,2018,28(11):824-828.

[4] Cai Z,Wang H,Yuan S,et al. Plasma big Endothelin-1 level predicted 5-year major adverse cardiovascular events in patients with coronary artery ectasia[J]. Front Cardiovasc Med,2021,8:768431.

[5] Markis JE,Joffe CD,Cohn PF,et al. Clinical significance of coronary arterial ectasia[J]. Am J Cardiol,1976,37(2):217-222.

[6] 乔树宾,崔锦钢,蒋晓威,等. 冠状动脉扩张症的新分型及临床意义[J]. 中华心血管病杂志,2018,46(10):756-9.

[7] Boles U,Eriksson P,Zhao Y,et al. Coronary artery ectasia:remains a clinical dilemma[J]. Coron Artery Dis,2010,21(5):318-320.

[8] Richards GHC,Hong KL,Henein MY,et al. Coronary artery ectasia:review of the non-atherosclerotic molecular and pathophysiologic concepts[J]. Int J Mol Sci,2022,23(9):5195.

[9] Malviya A,Jha PK,Mishra A. Isolated coronary artery ectasia:clinical,angiographic,and follow up characteristics[J]. Indian Heart J,2017,69(5):619-623.

[10] Zografos T,Kokladi M,Katritsis D. Coronary artery ectasia and systolic flow cessation in a patient with hypertrophic cardiomyopathy:a case report[J]. Int J Cardiol,2010,45(3):e114-e115.

[11] Aparicio A,Cuevas J,Morís C,et al. Slow coronary blood flow:pathogenesis and clinical implications[J]. Eur Cardiol,2022,17:e08.

[12] Zografos TA,Korovesis S,Giazitzoglou E,et al. Clinical and angiographic characteristics of patients with coronary artery ectasia[J]. Int J Cardiol,2013,167(4):1536-1541.

[13] Wei W,Wang X,Huang Z,et al. Difference in inflammation,atherosclerosis,and platelet activation between coronary artery aneurysm and coronary artery ectasia[J]. J Thorac Dis,2020,12(10):5811-5821.

[14] Gulec S,Atmaca Y,Kilickap M,et al. Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia[J]. Am J Cardiol,2003,91(8):996-999,A7.

[15] Eitan A,Roguin A. Coronary artery ectasia:new insights into pathophysiology,diagnosis,and treatment[J]. Coron Artery Dis,2016,27(5):420-428.

[16] Soto ME,Reyes-Villatoro MA,Márquez R,et al. Evaluation and analysis of plasma soluble adhesion molecules in patients with coronary ectasia and atherosclerotic coronary artery disease[J]. Arch Med Res,2014,45(6):478-483.

[17] Gunasekaran P,Stanojevic D,Drees T,et al. Prognostic significance,angiographic characteristics and impact of antithrombotic and anticoagulant therapy on outcomes in high versus low grade coronary artery ectasia:a long-term follow-up study [J]. Catheter Cardiovasc Interv,2019,93(7):1219-1227.

[18] Doi T,Kataoka Y,Noguchi T,et al. Coronary artery ectasia predicts future cardiac events in patients with acute myocardial infarction[J]. Arterioscler Thromb Vasc Biol,2017,37(12):2350-2355.

[19] Schoenhagen P,Ziada KM,Vince DG,et al. Arterial remodeling and coronary artery disease:the concept of "dilated" versus "obstructive" coronary atherosclerosis[J]. J Am Coll Cardiol,2001,38(2):297-306.

[20] Nichols L,Lagana S,Parwani A. Coronary artery aneurysm:a review and hypothesis regarding etiology[J]. Arch Pathol Lab Med,2008;132(5):823-828.

[21] Mavrogeni S. Coronary artery ectasia:from diagnosis to treatment[J]. Hellenic J Cardiol, 2010 ,51(2):158-163.

[22] Fan CH,Hao Y,Liu YH,et al. Anti-inflammatory effects of rosuvastatin treatment on coronary artery ectasia patients of different age groups[J]. BMC Cardiovasc Disord,2020,20(1):330.

[23] Li JJ,Li Z,Li J. Is any link between inflammation and coronary artery ectasia?[J]. Med Hypotheses,2007,69(3):678-683.

[24] Androulakis AE,Andrikopoulos GK,Kartalis AN,et al. Relation of coronary artery ectasia to diabetes mellitus[J]. Am J Cardiol,2004,93(9):1165-1167.

[25] Huang QJ,Liu J,Chen MH,et al. Relation of diabetes to coronary artery ectasia:a meta-analysis study [J]. Anadolu Kardiyol Derg,2014,14(4):322-327.

[26] Cai Z,Liu J,Wang H,et al. Diffuse coronary artery dilation predicted worse long-term outcomes in patients with coronary artery ectasia[J]. Int J Cardiol,2020,319:20-25.

[27] Dahhan A. Coronary artery ectasia in atherosclerotic coronary artery disease,inflammatory disorders,and sickle cell disease[J]. Cardiovasc Ther,2015,33(2):79-88.

[28] McCrindle BW,Rowley AH,Newburger JW,et al. Diagnosis,treatment,and long-term management of Kawasaki disease:a scientific statement for health professionals from the American Heart Association[J]. Circulation,2017,135(17):e927-e999.

[29] Abou Sherif S,Ozden Tok O,Ta?k?ylü ?,et al. Coronary artery aneurysms:a review of the epidemiology,pathophysiology,diagnosis,and treatment[J]. Front Cardiovasc Med,2017,4:24.

[30] Gülec S,Aras O,Atmaca Y,et al. Deletion polymorphism of the angiotensin Ⅰ converting enzyme gene is a potent risk factor for coronary artery ectasia [J]. Heart,2003,89(2):213-214.

[31] Lu TP,Chuang NC,Cheng CY,et al. Genome-wide methylation profiles in coronary artery ectasia[J]. Clin Sci (Lond),2017,131(7):583-594.

[32] Turhan H,Erbay AR,Yasar AS,et al. Comparison of C-reactive protein levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease[J]. Am J Cardiol,2004,94(10):1303-1306.

[33] Li JJ,Nie SP,Qian XW,et al. Chronic inflammatory status in patients with coronary artery ectasia[J]. Cytokine,2009,46(1):61-64.

[34] Dereli S,?erik ?B,Kaya A,et al. Assessment of the relationship between C-reactive protein-to-albumin ratio and the presence and severity of isolated coronary artery ectasia[J]. Angiology,2020,71(9):840-846.

[35] Yilmaz M,Kayan?i?ek H,Korkmaz H,et al. A new inflammatory marker:elevated eosinophil-tolymphocyte ratio associated with presence and severity of isolated coronary artery ectasia[J]. Cardiovasc J Afr,2020,31(5):227-235.

[36] Tosu AR,Biter H?. Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia[J]. Arch Med Sci Atheroscler Dis,2021,6:e152-e157.

[37] Triantafyllis AS,Kalogeropoulos AS,Rigopoulos AG,et al. Coronary artery ectasia and inflammatory cytokines:link with a predominant Th-2 immune response?[J]. Cytokine ,2013,64(1):427-432.

[38] Genda A,Nakayama A,Shimizu M,et al. Coronary angiographic characteristics in Japanese patients with heterozygous familial hypercholesterolemia[J]. Atherosclerosis,1987,66(1-2):29-36.

[39] Jafari J, Daum A, Hamed JA, et al. Low high-density lipoprotein cholesterol predisposes to coronary artery ectasia[J]. Biomedicines,2019,7(4):79.

[40] Boles U,Pinto RC,David S,et al. Dysregulated fatty acid metabolism in coronary ectasia:an extended lipidomic analysis[J]. Int J Cardiol,2017,228:303-308.

[41] Sun M,Gao X,Zhang D,et al. Identification of biomarkers for unstable angina by plasma metabolomic profiling[J]. Mol Biosyst,2013,9(12):3059-3067.

[42] Al-Zakhari R,Aljammali S,Galligan S,et al. Coronary artery ectasia:a case report discussing the causes,diagnosis,and treatment[J]. Cureus,2021,13(4):e14431.

[43] Maehara A,Mintz GS,Ahmed JM,et al. An intravascular ultrasound classification of angiographic coronary artery aneurysms[J]. Am J Cardiol,2001,88(4):365-370.

[44] Schaar JA,De Korte CL,Mastik F,et al. Characterizing vulnerable plaque features with intravascular elastography[J]. Circulation,2003,108(21):2636-2641.

[45] Leschka S,Stolzmann P,Scheffel H,et al. Prevalence and morphology of coronary artery ectasia with dual-source CT coronary angiography[J]. Eur Radiol,2008,18(12):2776-2784.

[46] Antonopoulos AS,Siasos G,Oikonomou E,et al. Characterization of vascular phenotype in patients with coronary artery ectasia:the role of endothelial dysfunction[J]. Int J Cardiol,2016,215:138-139.

[47] Sengupta D,Kahn AM,Kung E,et al. Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease[J]. Biomech Model Mechanobiol,2014,13(6):1261-1276.

[48] Kawsara A,Nú?ez Gil IJ,Alqahtani F,et al. Management of coronary?artery?aneurysms[J]. JACC Cardiovasc Interv,2018,11(13):1211-1223.

[49] Ozcan OU,Atmaca Y,Goksuluk H,et al. Effect of diltiazem on coronary artery flow and myocardial perfusion in patients with isolated coronary artery ectasia and either stable angina pectoris or positive myocardial ischemic stress test[J]. Am J Cardiol,2015,116(8):1199-1203.

[50] Gercken U,Lansky AJ,Buellesfeld L,et al. Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results[J]. Catheter Cardiovasc Interv,2002,56(3):353-360.

[51] Turco MA,Buchbinder M,Popma JJ,et al. Pivotal,randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease:eight-month angiographic and clinical results from the Symbiot Ⅲ trial [J]. Catheter Cardiovasc Interv,2006,68(3):379-388.

[52] Esposito L,Di Maio M,Silverio A,et al. Treatment and outcome of patients with coronary artery ectasia:current evidence and novel opportunities for an old dilemma[J]. Front Cardiovasc Med,2022,8:805727.

[53] Oushy S,Rinaldo L,Brinjikji W,et al. Recent advances in stent-assisted coiling of cerebral aneurysms[J]. Expert Rev Med Devices,2020,17(6):519-532.

[54] Saccà S,Pacchioni A,Nikas D. Coil embolization for distal left main aneurysm:a new approach to coronary artery aneurysm treatment[J]. Catheter Cardiovasc Interv,2012,79(6):1000-1003.

[55] Kim Y. Stent-assisted coil embolization of large coronary artery aneurysm under intravascular ultrasound guidance[J]. Cardiol J,2024,31(2):359-360.

[56] Qiao S,Xiaowei J,Cui J,et al. Double-layer bare metal stents in the treatment of coronary artery aneurysm:experience and outcomes in nine patients[J]. EuroIntervention,2019,15(7):644-646.

相似文献/References:

[1]赵丹 周鹏.达比加群及其逆转剂在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):801.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.034]
　ZHAO DanZHOU Peng.Dabigatran and Reversal in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(10):801.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.034]
[2]陈元 楚天舒 武力勇.瘦素抵抗、瘦素受体基因多态性与冠状动脉粥样硬化性心脏病的相关性进展[J].心血管病学进展,2019,(8):1130.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.015]
　CHEN Yuan,CHU Tianshu,WU Liyong.Leptin Resistance,Leptin Receptor Gene Polymorphism and Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(10):1130.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.015]
[3]石文坚 花蕾 孟祥光 袁义强.环状RNA在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2019,(9):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
　SHI Wenjian,HUA Lei,MENG Xiangguang,et al.CircRNA in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(10):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
[4]孙涛 左权 周辉 刘安康 梁诚 汤圣兴.末梢桡动脉和无鞘技术在冠状动脉介入治疗中的应用现状[J].心血管病学进展,2020,(5):456.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.005]
[5]奚云萍 臧雁翔 李为民.临床SYNTAX计分及其衍生计分在冠心病血运重建预后中的应用价值[J].心血管病学进展,2020,(5):452.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
　XI Yunping,ZANG Yanxiang,LI Weimin.Value of Clinical SYNTAX Score and Its Derivative Score in Prognosis of Coronary Artery Disease with Revascularization[J].Advances in Cardiovascular Diseases,2020,(10):452.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
[6]肖亚楠 高传玉 朱中玉.低剂量替格瑞洛在冠心病中的应用前景[J].心血管病学进展,2020,(7):706.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.009]
　XIAO Yanan,GAO Chuanyu,ZHU Zhongyu.Application Prospects of Low-dose Ticagrelor in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2020,(10):706.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.009]
[7]史云聪,王立立 郭艺芳.维生素D与心血管疾病相关性研究进展[J].心血管病学进展,2020,(8):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
　SHI YuncongWANG LiliGUO Yifang.Vitamin D And Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(10):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
[8]李英  刘兴鹏.常见心血管病服药依从性[J].心血管病学进展,2020,(10):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
　LI Ying,LIU Xingpeng.Medication Adherence For Common Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(10):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
[9]汪沛志 袁晋青.冠状动脉扩张症的认识及进展[J].心血管病学进展,2021,(3):193.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.001]
　WANG Peizhi,YUAN Jinqing.Coronary Artery Ectasia: A Current Literature Review[J].Advances in Cardiovascular Diseases,2021,(10):193.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.001]
[10]肖亚楠 高传玉.经皮冠脉介入术后短程双联抗血小板治疗的研究进展[J].心血管病学进展,2021,(4):318.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.008]
　XIAO Yanan,GAO Chuanyu.Short-term Dual Antiplatelet Therapy after Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2021,(10):318.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.008]

更新日期/Last Update: 2024-11-01